PROJECT
Background
Biomacromolecules that are theoretically untargetable by small molecules and macromolecules are named “undruggable” (meaning that they cannot be discovered by conventional drug discovery platform technologies).
Taking proteins as an example, it was proposed that 75~85% of all proteins are undruggable proteins. Typical examples of andragalable biomacromolecules are various causative molecules of cancer, but they are also found in the cause of many other diseases.
Overview of Intermediate Molecular Drug Discovery
List of Major Research Projects
Drug Discovery Platform Technology Business

Drug discovery platform technology based on protein secondary structure
β-strand bridge peptides
Drug Discovery Platform Technology Business

Drug discovery platform technology based on nucleic acid skeleton
Information will be disclosed after the patent application is completed.
Drug Discovery Platform Technology Business

Screening method based on protein secondary structure and nucleic acid structure
moreDrug Discovery Business

Anticancer Drug Development Project
Information will be disclosed after the patent application is completed.
Drug Discovery Business

Project to Develop a Treatment for Amyotrophic Lateral Sclerosis
Information will be disclosed after the patent application is completed.